However, more relevant to the need for a prompt assay within cGMP cell expansion timelines, after 1W-OM-PL treatment five biomarkers ALPL, COL1A2, DCN, ELN, RUNX2 represented the osteogenic “signature genes” significantly upregulated in all phenotypic contexts (Fig 5E, 1W Venn diagram). Here, ELN is linked to ocular melanoma.